Hydralazine target: From blood vessels to the epigenome
Hydralazine was one of the first orally active antihypertensive drugs developed. Currently, it is used principally to treat pregnancy-associated hypertension. Hydralazine causes two types of side effects. The first type is an extension of the pharmacologic effect of the drug and includes headache, n...
| Main Authors: | , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
BioMed Central
2006
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413557/ |